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Abstract
Biofortification of cassava with the provitamin A carotenoid b-carotene is a potential mechanism for alleviating vitamin A deficiency.
Cassava is a staple food in the African diet, but data regarding the human bioavailability of b-carotene from this food are scarce. The objec-
tive of the present study was to evaluate provitamin A-enhanced cassava as a source of b-carotene and vitamin A for healthy adult women.
The study was a randomised, cross-over trial of ten American women. The subjects consumed three different porridges separated by 2 week
washout periods. Treatment meals (containing 100 g cassava) included: biofortified cassava (2 mg b-carotene) porridge with added oil
(15 ml peanut or rapeseed oil, 20 g total fat); biofortified cassava porridge without added oil (6 g total fat); unfortified white cassava
porridge with a 0·3 mg retinyl palmitate reference dose and added oil (20 g total fat). Blood was collected six times from 20·5 to 9·5 h
post-feeding. TAG-rich lipoprotein (TRL) plasma was separated by ultracentrifugation and analysed using HPLC with coulometric array
electrochemical detection. The AUC for retinyl palmitate increased after the biofortified cassava meals were fed (P,0·05). Vitamin A
conversion was 4·2 (SD 3·1) and 4·5 (SD 3·1)mg b-carotene:1mg retinol, with and without added oil, respectively. These results show
that biofortified cassava increases b-carotene and retinyl palmitate TRL plasma concentrations in healthy well-nourished adult women,
suggesting that it is a viable intervention food for preventing vitamin A deficiency.
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Vitamin A deficiency is a leading cause of morbidity and
mortality, especially in young children and pregnant and
lactating women(1). Food-based interventions focused on
alleviating vitamin A deficiency in susceptible populations
have advantages over supplementation and fortification
programmes, especially in rural areas, because they can pro-
vide a sustainable source of a variety of nutrients and other
phytochemicals without the recurring transport and adminis-
tration costs of these other methods(2).
Cassava is a root vegetable, specifically a starchy tuber,
with many positive attributes. It can survive droughts, is
inexpensive, resistant to pests and easy to grow. Although it
is a valuable source of energy, typically it is a poor source
of provitamin A carotenoids(3,4). Not coincidently, it is a
staple crop in three regions where vitamin A deficiency is
prevalent: Africa, South America and Southeast Asia(2,5).
Recently, multi-national non-governmental organisations (esp-
ecially HarvestPlus) have enhanced the provitamin A carotenoid
content of cassava, either through traditional plant-breeding
(HarvestPlus) or bioengineering (BioCassavaPlus)(2,6,7). Their
efforts have resulted in yellow-orange-fleshed cassava cultivars
with moderately high concentrations of b-carotene and other
provitamin A carotenoids. Only HarvestPlus varieties have
been disseminated in countries to date.
Cassava contains cyanogenic compounds that require
processing in order to make it safe for consumption. Unfor-
tunately, the type of processing, as well as cooking tem-
perature and time(8), can also decrease the retention of
carotenoids(9,10).
In general, carotenoid bioavailability in food is considered
to be low, with the bioconversion rate of b-carotene estimated
to be as low as 12mg to 1mg retinol(11). However, biofortified
cassava enriched with provitamin A carotenoids has success-
fully maintained vitamin A status in Mongolian gerbils(12).
Thus, more information is required on the bioavailability
and bioconversion of carotenoids from cassava in human
subjects. Also, since provitamin A bioavailability generally
*Corresponding author: B. J. Burri, fax þ1 530752 4390, email betty.burri@ars.usda.gov
Abbreviations: BF, biofortified cassava without oil; BFO, biofortified cassava with oil; CIAT, International Center for Tropical Agriculture; ppm, parts per
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increases with the addition of fat(11), the effect of consuming
varying amounts of fat with biofortified cassava is of interest.
Both common white and provitamin A-enriched cassava
were fed to ten healthy well-nourished American women.
The objectives of the present study were to estimate the effec-
tiveness of biofortified cassava for increasing provitamin A
carotenoid and vitamin A concentrations in healthy adult
women, and to determine whether increased fat in the diet
improved these concentrations.
Experimental methods
Subjects
A total of twelve healthy, non-smoking, non-pregnant women
aged 21–44 years were enrolled in the study. A woman was
judged as ‘healthy’ if she had a BMI of 18–30 kg/m2, blood
pressure less than 135/90 mmHg and TAG, cholesterol, total
protein, electrolytes, kidney and liver function tests (such as
blood urea N), Hb, haematocrit, erythrocytes and leucocytes
within the clinically normal ranges (Table 1). Exclusion criteria
included the use of medications that affect retinoid, carotenoid
or cholesterol absorption from food such as fat-, TAG- or
cholesterol-lowering medications, medicines containing high
dosages of retinoids, vitamin A or carotenoid supplements,
illegal drugs or tobacco. In addition, subjects could not be
allergic to cassava, peanuts or peanut oil. The present study
was conducted according to the guidelines laid down in the
Declaration of Helsinki, and all procedures involving human
subjects were approved by the University of California,
Davis Institutional Review Board. Written informed consent
was obtained from all subjects.
Cassava preparation
Biofortified cassava, cross-bred to contain high amounts
of b-carotene (Genotype GM 905-69), was provided by the
International Center for Tropical Agriculture (CIAT). GM905-
69 was derived from crosses among cassava genotypes
from South and Central America that naturally contain little
b-carotene, because the African germplasm lacked enough
genetic variability to allow for the development of b-carotene-
biofortified cassava. Typical unfortified white cassava was
purchased from Las Montan˜as Supermarket. Initial weights of
the cassava varieties were 3·44 and 3·38 kg for the biofortified
and unfortified white cassava, respectively. Upon arrival at
the Western Human Nutrition Research Center, roots were
washed, peeled and flash frozen and then stored in a food-
safe freezer at 2208C in the Metabolic Kitchen and Human
Feeding Laboratory until use. For preparation, roots were
thawed overnight at 48C and then rinsed twice with deionised
water. Tips from the distal and proximal ends were removed
(1–2 cm) and discarded and the roots were diced (about
1 cm3). Deionised water (four volumes) was added to the
chopped roots and stirred. The roots were then refrigerated
overnight for 12 h, after which they were drained to remove
cyanogenic glycosides. Another round of four volumes of
deionised water was added and subsequently drained after
2 h. This process was repeated every 2 h for 8 h. Following the
last draining, the cassava cubes were rinsed with deionised
water and lightly simmered (958C) in ten volumes of deionised
water for 30 min. Constant stirring of the cassava helped to
ensure its homogeneity and minimised variations in carotenoid
concentration. Cooked cassava was drained, cooled and
aliquots were stored in 50 ml polypropylene screw-capped
tubes wrapped in aluminium foil under N2 at 2208C in the
food-safe freezer. All procedures were conducted under dim
lights to minimise light exposure. Fig. 1 shows the biofortified
cassava before and after preparation.
Cassava preparations were analysed for cyanogenic glyco-
sides by two methods. Each step of the cassava preparation
was monitored by our laboratory using a La Motte colorimetric
assay (LaMotte). Cassava preparations (1 g) were placed in a
15 ml test-tube, sliced into small pieces, mashed with a mortar
and then mixed with 7 ml deionised water by vortexing for
1 min. Preparations were left at room temperature for 20 min,
then vortexed for 20 s and filtered through a 0·2mm Pall
Gelman Acrodisc (Sigma Aldrich) into a LaMotte test-tube.
The water extract was tested using the LaMotte Cyanide in
Water Test Kit, according to the manufacturer’s specifications.
Table 1. Subject demographics and blood chemistries
(Mean values, ranges and standard deviations)
US units UK units
Mean SD Normal range* Mean SD Normal range*
Age (years) 29·3 8·8 NA 29·3 8·8 NA
Body weight (kg) 63·8 6·3 NA 63·8 6·3 NA
BMI (kg/m2) 23·1 2·3 18·5–25 23·1 2·3 18·5–25
Glucose 822 mg/l 45 mg/l 700–1100 mg/l 2·13 mmol/l 0·06 mmol/l 1·81–2·84 mmol/l
Total cholesterol 1590 mg/l 160 mg/l ,2250 mg/l 4·11 mmol/l 0·41 mmol/l ,5·82 mmol/l
HDL-cholesterol 566 mg/l 102 mg/l .600 mg/l 1·46 mmol/l 0·26 mmol/l .1·55 mmol/l
LDL-cholesterol 867 mg/l 170 mg/l ,1000 mg/l 2·24 mmol/l 0·44 mmol/l ,2·59 mmol/l
TAG 787 mg/l 280 mg/l 530–1390 mg/l† 2·04 mmol/l 0·72 mmol/l 1·37–3·59 mmol/l†
Hb 131 mg/l 6 mg/l 120–160 mg/l 0·34 mmol/l 0·02 mmol/l 0·31–41 mmol/l
Haematocrit (%) 38·5 1·9 37–48 38·5 1·9 37–48
NA, not available.
* Normal range for females.
† Normal range from 10 to 49 years old.
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For confirmation, the final prepared samples were sent to an
outside laboratory (Applied Specialization and Consulting
LLC) and analysed using alkaline hydrolysis, distillation and
ion chromatography with pulsed amperometric detection.
Dietary protocols
Each subject consumed three randomised dietary interven-
tions of cassava porridge separated by 2-week washout
periods. Before each intervention, subjects were required to
eat a diet low in vitamin A and carotenoids (Table 2). On
the first 4 d, subjects were instructed on how to reduce their
dietary intake of provitamin A carotenoids and vitamin A
(the dietary guidance for the subjects is provided as Sup-
plementary material, available online) and were required to
complete a 4 d food record to assess their adherence with
the dietary restriction. On the 3 d leading up to each interven-
tion, subjects were provided with nutrient-controlled research
meals and required to eat only from what was provided to
them, but were not required to eat everything. The nutrient-
controlled meals were designed by a registered dietitian and
were prepared in the Metabolic Kitchen of the Western
Human Nutrition Research Center, then given to the subjects
for reheating. The meals were low in fat, protein, carotenoids
and vitamin A. Nutrient data were calculated using the Nutri-
tion Data System for Research (The Nutrition Coordinating
Center, University of Minnesota) software. The United States
Department of Agriculture Nutrient Data Laboratory is the
primary source of the nutrient values and nutrient compo-
sition in this database, which contains information on over
18 000 foods. A total of five aliquots were collected from
each of the test meals and analysed for vitamin A and provita-
min A content. The extraction procedure used was similar to
that described by Howe et al.(12). Briefly, approximately 1 g
homogenised cassava was mixed with 6 ml ethanol (contain-
ing butylated hydroxytoluene 0·05 % (w/v)) and 120ml potass-
ium hydroxide (80 % (w/v)) and saponified at 608C for 10 min,
before 3 ml deionised water were added and it was extracted
twice with 3 ml hexane. The diet consumed on the 3 d prior
to the test day contained 107·8mg b-carotene, 181·7mg
b-cryptoxanthin and 0mg a-carotene and retinol by analysis
(Table 3). Total calculated energy was 9113 kJ (2178 kcal),
with 67·7 g protein (12 % of energy), 24 g fat (9·7 % of
energy) and 428·9 g carbohydrate (78·1 % of energy) (Table 3).
On each test day, subjects consumed one of the following
randomised porridge meals for breakfast: (1) b-carotene-
biofortified cassava porridge with oil, containing 100 g drained
cassava, 15 ml added rapeseed or peanut oil (20 g total fat) and
approximately 2 mg b-carotene; (2) biofortified cassava por-
ridge without added oil (6 g total fat); (3) unfortified white cas-
sava porridge with added rapeseed or peanut oil (20 g total fat)
containing a reference dose of 0·3 mg pure food-grade retinyl
palmitate. The test meals were consumed under supervision
by the Metabolic Kitchen and Human Feeding Laboratory staff.
We attempted to make this a double-blind study, wherein
the rest of the foods in the porridge masked the differences
in colour between yellow-orange biofortified and white unfor-
tified cassava. However, small differences in the colour of the
porridges could be detected by a trained eye. Furthermore,
adding oil changed the viscosity of the porridge slightly.
Therefore, the present study can best be called a single-
blind study, with the researchers blinded, conducted under
controlled conditions.
The cassava porridge consisted of 100 g cassava, 40 g quick-
cooking unfortified oatmeal (Quaker Oats), 150 g canned
pears in light syrup (Dole), 0·5 g salt (Sysco), 21·0 g honey
(Sue Bee), 18·9 g raisins (Sysco) and 245·5 g unfortified rice
milk (Hain Celestial Group). For the first two subjects, 14·0 g
peanut oil was added to the test meals that included additional
oil. However, subjects complained about the taste and
viscosity of the porridges prepared with peanut oil (Hain
Celestial Group) and had difficulty eating them. Subsequently,
the peanut oil was replaced by 14·0 g rapeseed oil (Sysco) and
added to the test meals. Food-grade retinyl palmitate,
kindly donated by Kazi Jamil of the International Centre
for Diarrhoeal Disease Research, was diluted in peanut oil.
Each of the porridges was prepared immediately prior to
consumption.
A proximate analysis was performed on each of the biofor-
tified cassava porridges (Covance), but was calculated for the
unfortified white cassava porridge using the Nutrition Data
System for Research (The Nutrition Coordinating Center,
University of Minnesota) software (Table 2). Macronutrient
and micronutrient concentrations for Fe, phytate, vitamin C
Fig. 1. Appearance of biofortified cassava before and after processing,
including the drained water after simmering.
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and other micronutrients and food constituents of interest
were also estimated with the Nutrition Data System for
Research (The Nutrition Coordinating Center, University of
Minnesota) software (Table 3). The three test meals were
served in random order. An evening meal that was low in
fat, vitamin A and provitamin A carotenoids was fed 9.5 h
after the test meal. The evening meal provided the same
nutrient specification as the foods provided during the 3 d
before the test.
Isolation of postprandial lipoprotein fraction
Throughout all blood processing procedures and analyses,
laboratory workers were blinded to the dietary treatment
received by the subject. Blood was typically collected by a
catheter inserted into an anticubital vein. Approximately
30 min before the porridge test meal, the catheter was
inserted and a baseline sample of 13 ml blood was collected.
Baseline blood was used for complete blood count analysis
performed on a CellDyn 3200 (Abbott Laboratories), as well
as for carotenoid and vitamin A tests. Postprandial blood
samples (10 ml) were collected at 2, 3·5, 5, 7·25 and 9·5 h
after the test meal. After the 9·5 h blood draw, the catheter
was withdrawn.
Blood was transferred into EDTA vacutainers, wrapped
in foil to protect from light and placed on ice. Plasma was
separated by centrifugation at 1300 g for 10 min at 48C on a
Sorvall DuPont RC-3C (Thermo-Fisher Scientific). All plasma
Table 3. Estimated macro- and micronutrient composition for run-in menu, test day meal excluding porridge and for
white cassava porridge alone*
Analyte Run-in menu Test day excluding porridge Porridge with oil Porridge without oil
Energy
kcal 2178 1781 762 638
kJ 9112 7451 3188 2669
Carbohydrates (g) 428·9 341·5 142·3 142·3
Fat (g) 24·2 24·5 19·5 5·5
Protein (g) 67·7 51·0 9·5 9·5
Fibre (g) 30·9 17·8 9·0 9·0
Vitamin A (mg) 0·004 0·001 0·001† 0·001†
b-Carotene (mg) 0·002 0·009 0·007 0·007
a-Carotene (mg) 0·0 0·0 0·0 0·0
b-Cryptoxanthin (mg)† 0·0 0·0 0·0 0·0
Oxalic acid (mg) 134·8 110·6 1273·5 1271·7
Phytic acid (mg) 922·2 445·9 407·1 407·1
Cu (mg) 1·4 1·0 0·5 0·5
Fe (mg) 17·8 14·6 3·1 3·1
K (mg) 2163·0 1373·0 740·0 740·0
Se (mg) 110·9 97·9 16·3 16·3
Zn (mg) 8·7 7·6 2·0 2·0
Folate (mg) 535·0 398·0 37·0 37·0
Niacin (mg) 20·6 17·3 4·1 4·1
Riboflavin (mg) 1·3 1·3 0·3 0·3
Vitamin C (mg) 19·7 33·7 15·1 15·1
Vitamin D (mg) 0·4 0·4 0·0 0·0
* Values by calculation using the Nutrition Data System for Research version 2009 (The Nutrition Coordinating Center, University of Minne-
sota). Data are based on typical (non-biofortified) white cassava.
† Vitamin A was added in the form of a reference dose of retinyl palmitate, but was not included in this table.
Table 2. Composition of cassava porridge meals (per 100 g)
Biofortified with oil* Biofortified without oil* White with oil†
Energy
kcal 704·0 631·0 762·0
kJ 2945·5 2640·1 3188·2
Fat (g) 19·9 6·0 19·5
Carbohydrates (g) 127·0 139·8 142·3
Protein (g) 6·1 6·0 9·5
Ash (g) 1·5 1·5 3·7
Moisture (g) 420·9 407·4 600·0
Vitamin A (mg)* 0 0 0·30‡
b-Carotene (mg)* 2·02 2·02 0·099
a-Carotene (mg)* 0 0 0
b-Cryptoxanthin (mg)* 0·050 0·050 0·019
* As analysed.
† As calculated using Nutrition Data System for Research (The Nutrition Coordinating Center, University of
Minnesota) software.
‡ Vitamin A was added in the form of a reference dose of retinyl palmitate.
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handling was carried out under gold fluorescent lights in order
to protect these compounds.
The TAG-rich lipoprotein (TRL) fraction, containing newly
absorbed carotenoids and retinyl palmitate, was separated
from plasma by ultracentrifugation(13). A 1 ml aliquot of
plasma was overlaid with NaCl salt solution (density ¼ 1·006
kg/l) in 2·2 ml polyallomer ultracentrifuge tubes (Beckman
Coulter, Inc.). Samples were ultracentrifuged at 100 000 g for
20 min at 48C in a Beckman Coulter Optima TLX (Beckman
Coulter, Inc.), with the use of a swing-out rotor-type Beckman
TLA 100 (Beckman Coulter, Inc.). Tubes were removed from
the ultracentrifuge, placed in a Beckman Centritube Slicer
(Beckman Coulter, Inc.) and sliced at a fixed position. These
procedures resulted in a reproducible TRL fraction consisting
of chylomicrons and large VLDL. Approximately 100ml of the
plasma TRL fraction was removed and dispensed into a 15 ml
test-tube, along with 100ml of echinenone as an internal stan-
dard, and immediately deproteinised with 1 ml methanol
before it was extracted twice with 1 ml hexane. The hexane
layers were dried under N2 and reconstituted in 100ml 90:10
(v/v) methanol–isopropanol. TAG, cholesterol and HDL con-
centrations were measured at each blood draw time point
using a clinical chemistry analyser (Integra 400 Plus, Roche
Diagnostics), while LDL concentrations were measured by
difference.
Analytical procedures
Food samples and the plasma TRL fraction were analysed by
HPLC using reversed-phase chromatography with coulometric
array electrochemical detection. Carotenoids and retinoids
were separated by an ESA MD-150 column (150 mm £
3·2 mm; Dionex (ESA)(14)). The HPLC consisted of an ESA
model 582 solvent delivery system, 542 autosampler and
5600 Coularray electrochemical detector, with a CH30 Eppen-
dorf column heater (Eppendorf). The gradient mobile phases
used were: solvent A (methanol–0·2 M-aqueous ammonium
acetate, 90:10 (v/v), pH 4) and solvent B (methanol–isopropa-
nol–1 M aqueous ammonium acetate, 78:20:2 (by vol.), pH 4).
The column was maintained at 378C throughout. The follow-
ing gradient was used: the mobile phase was maintained at
0 % solvent B from 0 to 10 min, before increasing linearly
from 10 to 20 min to 80 % B and from 20 to 27 min to 100 %
B. It was then abruptly changed to 0 % B at 27 min and main-
tained until the runtime ended at 32 min. Cell potential settings
were 200, 400, 500 and 700 mV. Flow rate was 0·8 ml/min and
the injection volume was 20ml. All samples were analysed in
duplicate. ESA Coularray software version 3.1 (Thermo
Fisher Scientific) was used to collect and integrate all chroma-
tographic data. b-Carotene and echinenone responded predo-
minantly at 400 mV and retinyl palmitate at 700 mV.
Methanol, isopropanol and ammonium acetate were
purchased from Thermo Fisher Scientific. The calibration stan-
dards b-carotene, retinol and retinyl palmitate were purchased
from Sigma-Aldrich and b-cryptoxanthin and a-carotene
standards were purchased from Santa Cruz Biochemicals.
Echinenone, an internal calibration standard, was purchased
from Carotenature. A pooled plasma sample purchased from
UTAK was used to evaluate inter-assay precision of the
plasma TRL fraction. Inter-assay precision ranged between
5 and 11 % for carotenoids and retinoids.
Data analysis
Areas under the concentration–time curve (AUC) were calcu-
lated using trapezoidal approximation after subtracting initial
fasting concentrations for retinyl palmitate and TAG, while
the AUC for b-carotene was calculated by subtracting the
unfortified white cassava control group concentrations at
each time point.
Many retinyl esters in the plasma TRL fraction were too low in
concentration to quantify accurately. As the postprandial retinyl
ester profile is relatively constant, retinyl palmitate, the most
common retinyl ester, can be used to estimate total retinyl
ester formation(15,16). With retinyl palmitate absorption typically
ranging between 75 and 99 %(17,18), we assumed a mid-range
recovery of 90 % retinyl palmitate.
To quantify the bioavailability of b-carotene from the
cassava porridges, fractional absorption was calculated
as described by O’Neill & Thurnham(19). Absorption calculations
were estimated using the assumption that the t1/2 of b-carotene,
retinyl palmitate and chylomicrons were equivalent
(0·192 h)(20,21). The plasma volume (ml) ¼ 927 þ (31·47 £
body weight in kg)(22) and the molecular mass was 536·9 for
b-carotene.
Fractional absorption ¼ ððln 2Þ=t1=2 £ ðAUC £mass
£ plasma volumeÞÞ=oral dose:
The percentage of b-carotene absorbed was calculated in
two ways using the sum of b-carotene plus retinyl palmitate
AUC(13,19). The first calculation assumed that 1 mol of b-caro-
tene formed 1 mol of retinyl palmitate, which would happen
by eccentric cleavage(23). The second calculation assumed cen-
tral cleavage of b-carotene, the major path of retinyl palmitate
formation. In central cleavage, 2 mol of retinyl palmitate are
formed from 1 mol of b-carotene(23).
To quantify bioconversion, vitamin A equivalence was
calculated as described by Li et al.(16). The retinyl palmitate
AUC values were converted to mass (nmol) retinyl palmitate
in the entire plasma pool by multiplying the TRL retinyl palmi-
tate concentration (nmol/l plasma) by the calculated plasma
volume (0·0427 litres £ kg body weight) of each subject(24,25).
Vitamin A (nmol) formed from the biofortified cassava ¼
(retinyl palmitate AUC after ingestion of the biofortified
cassava/retinyl palmitate AUC after ingestion of the white
cassava with retinyl palmitate reference dose) £ the vitamin
A reference dose of 1047·1 nmol.
Bioconversion factor for b-carotene in biofortified cassava ¼
b-carotene equivalents in biofortified cassava (nmol) £ molecular
weight (MW) b-carotene (536·8)/vitamin A formed from
b-carotene equivalents (nmol) £ MW retinol (286·5).
Differences in AUC and plasma TRL fraction values
were analysed using repeated-measures ANOVA, while vita-
min A equivalence differences were analysed using paired
M. R. La Frano et al.314
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Student t tests. One-tailed t tests were used for a priori
hypotheses, including the greater values of b-carotene and
retinyl palmitate expected in the biofortified meal with oil v.
without oil and the higher levels of b-carotene expected
in the biofortified meals v. the non-fortified white cassava.
Two tailed t tests were used when there was no hypothesis
regarding the direction of the effect. P values ,0·05 were
considered to be statistically significant. Statistical analyses
were performed using Statistical Analysis Systems statistical
software (Windows version 9.3; SAS Institute, Inc.).
Results
Subject characteristics
Healthy premenopausal women with normal BMI, cholesterol
and TAG were recruited for the present study. Their blood
chemistries and demographic characteristics are shown in
Table 1. Although the cassava meals were large (approxi-
mately 34 % of a 8368 kJ (2000 kcal) diet), ten of twelve sub-
jects completed the study and only one left because of
portion size. BMI, cholesterol and TAG concentrations did
not change during the study.
Two women left the study prior to completion, one for
scheduling conflicts, while the other disliked the porridge
portion size served. Table 1 shows the demographic character-
istics of the subjects who completed the study.
Composition of test meal
Biofortified cassava had pale cream-orange coloured flesh
before processing and thus appeared to be an unpromising
food source for enhancing carotenoids. However, gentle sim-
mering appeared to release carotenoids from the food matrix,
resulting in a yellow-orange appearance (Fig. 1).
The carotenoid concentrations and proximate analysis
measurements for the biofortified cassava porridges are
shown in Table 2. The macro- and micronutrient composition
of these porridges and of the entire run-in and test day meals
was also calculated with Nutrition Data System for Research
(The Nutrition Coordinating Center, University of Minnesota)
software (Table 3). The composition of these meals did not
differ substantially, except for the increase of fat in the
biofortified cassava with oil (BFO) test meal. The meals pro-
vided were low in vitamin A, provitamin A carotenoids and
fat, as planned.
Two lots of cassava were shipped from CIAT, 4 months
apart. The first lot was used for method development and
the second for the intervention study. Despite being from
the same cultivar, they had substantially different carotenoid
and cyanogenic glycoside concentrations. The b-carotene
concentration of the first lot was 8·0mg/g fresh weight,
while that of the second lot was 21·1mg/g after transporting,
freezing and thawing. Cassava roots were not waxed during
shipment or storage, and the second lot appeared to have
lost moisture, with a higher percentage dry weight (40.9 %)
and carotenoid concentration than typical. The b-carotene
concentrations for the second lot of cassava during processing
are shown in Table 4. Despite the developing yellow-orange
colour brought on by simmering, the b-carotene concentra-
tion in cassava actually decreased to 20·2mg/g, a loss of 4 %
during processing and cooking.
The small amount of b-carotene in the white cassava
appeared to decrease less than 1 % during these procedures.
These relatively small losses were probably due to the precau-
tions taken to preserve b-carotene content during processing,
such as heating the cassava to a temperature that resulted
in only a slight simmer and later reheating it for the least
amount of time necessary to reach minimal reheating tempera-
ture of 748C just prior to feeding.
The initial cyanide content of the biofortified cassava for
the first lot was 282 parts per million (ppm) and 5·5 ppm for
the second lot, a 50-fold difference. Low cyanogenic glycoside
concentrations were also found in the locally purchased
white cassava (5·3 ppm). The washing procedures developed
for the present study removed almost all of the cyanogenic
glycosides from the cassava. The effects of all processing
procedures, including transportation, freezing and thawing,
storage, washing and simmering, on cyanogen concentrations
are also shown in Table 4. Both testing methods showed
non-detectable cyanide concentrations in our final prepared
products (by both the in-house test and the confirmatory
testing by Applied Specialization and Consulting).
Postprandial TAG response
The difference in TAG AUC after consuming the high-fat BFO
(P,0·0002) and unfortified white cassava porridge with reti-
nyl palmitate (WCþRP; P,0·0001) meals was significant com-
pared with the low-fat (BF, biofortified cassava without oil)
meal (Table 5). After consuming the BFO and WCþRP
meals, plasma TRL fraction concentrations (nmol/l) rose
Table 4. Comparison of change in b-carotene and cyanide concentrations
before and after processing
Biofortified cassava
Lot no. 1 Lot no. 2 White cassava
Initial cyanide content (ppm) 280 5·51 5·27
Final cyanide content (ppm) 0 0 0
Initial b-carotene content (mg/g) 8* 21·1† 0·99
Final b-carotene content (mg/g) NT 20·2 0·99
ppm, Parts per million; NT, not tested.
* Fresh weight.
† Weight after transport, storage, freezing and thawing.
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within 2 h and maintained high concentrations for several
hours before decreasing (Fig. 2).
Postprandial b-carotene and retinyl palmitate response
The chromatography method used in the present study was
sensitive enough to measure b-carotene and retinyl palmitate
in the TRL fraction of plasma, but could not quantify all the
less common retinyl esters and carotenoids found in plasma
(data not shown). The TRL fraction had properties character-
istic of chylomicrons and large VLDL(26–30). This is appropri-
ate, as recently consumed b-carotene and retinyl palmitate
are found in both of these lipoprotein fractions(16,28,31).
The plasma TRL fraction b-carotene concentrations were
greater in the BFO meal than in the WC þ RP meal (P¼0·05;
Table 5). However, the BF meal was non-significantly different
from the WCþRP meal (P¼0·16). b-Carotene concentrations
were highest in the BFO meal, as expected, but the effect of
added oil compared with the BF meal was not significant
(P,0·4). The high b-carotene concentration after consuming
the BFO meal at 2 h suggests that added oil may have resulted
in faster absorption and metabolism of the b-carotene in the
biofortified cassava (Fig. 3).
Retinyl palmitate concentrations increased with all treat-
ments, because a retinyl palmitate reference dose was
included in the WCþRP meal (Fig. 4). The retinyl palmitate
AUC for the BFO and BF meals were significantly greater
than that of WCþRP (P,0·02 and P,0·05, respectively;
Table 5). The AUC for the BFO and BF meals were compared
with baseline (as retinyl palmitate would not be expected
to be generated by WC alone, without the retinyl palmitate
reference dose). Both increased significantly (P,0·0001 for
both). The retinyl palmitate AUC for the BFO meal did not
differ from the BF meal (P,0·35).
If we calculate the fractional absorption rate of b-carotene
and retinyl palmitate assuming eccentric cleavage, it was
33·6 % for the BFO meal and 27·4 % for the BF meal. Assuming
central cleavage, fractional absorption was 21·4 % for the BFO
meal and 16·7 % for the BF meal.
The mean vitamin A equivalence values for each of the
biofortified cassava meals are shown in Table 6. The mean
amount of b-carotene in the biofortified cassava, with the
vitamin A activity equivalent of 1mg retinol, ranged from
0·3 to 10·6 and 1·4 to 12·1mg for the BFO and BF meals,
respectively. The vitamin A equivalence values for the BFO
and BF meals was non-significantly different (P,0·44).
Discussion
The present study measured the effect of meals containing
b-carotene-biofortified cassava on the plasma TRL fraction
response of b-carotene and retinyl palmitate in healthy,
well-nourished women. It used ultracentrifugation to isolate
the plasma TRL fraction, which allows one to separate and
measure newly absorbed b-carotene and newly formed retinyl
palmitate to evaluate the bioavailability and bioconversion of
b-carotene from biofortified cassava in human subjects. One
important result from the present study is that feeding biofor-
tified cassava increased b-carotene and retinyl palmitate in the
plasma TRL fraction of these women. A second important
result is that b-carotene from biofortified cassava, with or
without added oil, was efficiently converted into vitamin A,
with an average vitamin A equivalence of 4·4:1.
The inclusion of fat in a meal can increase carotenoid
bioavailability(11). However, there is considerable debate
about the effect of different concentrations of fat on caroten-
oid absorption(11). In the present study, we compared the
effects of a low-fat meal (6 g) with a higher-fat meal (20 g).
Similar to other high-fat v. low-fat meal studies, the higher
amount of fat included in the BFO and WC þ RP meals
resulted in a significantly higher TAG AUC in the TRL
plasma fraction compared with the low-fat meal(30). Despite
Table 5. AUC values for TAG, b-carotene and retinyl palmitate in TAG-rich lipoprotein layer after
consumption of cassava porridges
(Mean values with their standard errors)
Biofortified cas-
sava with oil
Biofortified cas-
sava without oil
White cassava
retinyl palmitate
with oil
Variable Mean SEM Mean SEM Mean SEM
TAG (mmol £ h/l) 6·65* 1·59 2·11 0·54 6·83* 1·36
b-Carotene (normalised, nmol £ h/l) 32·41† 20·91 21·45 13·18 0‡
Retinyl palmitate (nmol £ h/l) 86·93* 12·75 75·88* 11·56 48·38 9·25
* Mean value was significantly different from the biofortified cassava without oil meal (P,0·0002).
† Mean value was significantly different from the white cassava meal (P¼0·05).
‡ Not detectable.
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Fig. 2. Change in TAG content in plasma TAG-rich lipoproteins after subjects
ingested biofortified cassava with oil ( ) containing 20 g total fat, bioforti-
fied cassava without oil ( ) containing 6 g total fat or an unfortified white
cassava meal with oil (retinyl palmitate, ) containing 20 g total fat. Values
are means, with their standard errors represented by vertical bars.
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this result, there was no significant difference in the AUC for
b-carotene or retinyl palmitate after consuming the higher-
fat BFO meal (v. the lower-fat BF meal). However, the AUC
for b-carotene was 66 % higher in the BFO meal (v. the BF
meal). Thus, the present results are somewhat equivocal, as
they suggest a real difference that did not attain statistical sig-
nificance because of our small number of subjects and the
large variation in b-carotene concentrations commonly
observed in human studies. The results from other investi-
gations on the effect of different amounts of fat on carotenoid
absorption are also mixed. Some studies indicate that only a
small amount of fat (3–5 g) is required to substantially
increase carotenoid bioavailability(32,33) and that b-carotene
bioavailability does not significantly improve when consumed
with a high-fat v. a low fat meal(34). Other studies show
improved absorption of b-carotene with high fat v. low fat
intake(30,35). Further studies are necessary to determine the
effects of adding fat to the diet.
Interestingly, although the two biofortified cassava meals
had similar bioavailability overall, the rate at which b-carotene
appeared in the plasma TRL fraction appeared to be different
(Fig. 3). However, the difference at this time point was not
statistically significant (P,0·21), presumably because of the
large variation in b-carotene concentrations in the group
and the low number of subjects. Although other studies
have reported rapid b-carotene appearances in the plasma
TRL fraction(13,36–38), their peak concentrations appeared
later. It is possible that the increased amount of fat in the
BFO resulted in b-carotene being packaged into chylomicrons
and secreted out of the enterocyte at a faster rate, as TAG con-
centrations also increased rapidly (Fig. 2). Another potential
influence on the absorption results for the present study was
the processing procedure. In order to remove cyanide, the
cassava was chopped, lightly heated in water and cooled
before being re-heated prior to serving. This may be relevant
because the chopping and heating involved in this procedure
effectively disrupts plant cell walls and carotenoid–protein
complexes and results in increased bioavailability(39,40).
The fractional absorption rates that we determined for the
BFO and BF meals are somewhat difficult to compare with
past human studies, because most of these studies had sub-
jects consuming high-dose b-carotene supplements given in
oil, which tend to be better absorbed than carotenoids from
food(13,19,28). Nevertheless, fractional absorption rates seen in
these studies ranged from 2·5 to 22·3 % for eccentric cleavage.
The only human study measuring fractional absorption of
b-carotene in food used red palm oil and had an absorption
of 65–68 %(38).
Furthermore, even when pure supplements are given,
absorption and conversion of b-carotene to vitamin A are
variable(41–43), in part because of polymorphisms in the
b,b-carotene-15,150-monoxygenase gene(44). Although the
b-carotene and retinyl palmitate AUC values in the present
study were low, they are similar to other studies using food-
derived b-carotene(16,45).
The vitamin A equivalence of the biofortified cassava was
4·2:1 for the BFO meal and 4·5:1 for the BF meal. This is com-
parable to a study that estimated vitamin A equivalence to be
3·7:1 in vitamin A-depleted Mongolian gerbils(12), an appropri-
ate small animal model for human provitamin A absorption
and metabolism(46). In addition, a human study that measured
b-carotene and retinyl palmitate response in the TRL plasma
fraction estimated biofortified cassava to have a vitamin A
equivalence of 2·8:1 (W. Liu, unpublished results). This effi-
cient conversion is also similar to that seen in other b-caro-
tene-biofortified foods, which appear to have higher
bioconversion rates than natural sources of this compound(47).
For example, studies in human subjects, mostly involving
stable isotopes, have estimated the vitamin A equivalence of
b-carotene in biofortified maize and rice to range from 3:1
to 6·5:1(16,45,48), while natural sources of b-carotene have
ranged from 10:1 to 28:1(25,49–53). These results indicate a
more efficient conversion than the present estimate (12mg
b-carotene:1mg retinol from food)(11).
The efficiency of b-carotene bioconversion appears to be
influenced by vitamin A status(47). The subjects in the present
study were well-nourished and probably had more than ade-
quate reserves of vitamin A. The absorption of b-carotene
from biofortified cassava might be greater in healthy people
with marginal vitamin A status. Furthermore, studies in target
populations of Africans or Asians with marginal vitamin A
status might produce even stronger results than those seen
in the present study (Figs. 3 and 4).
Table 6. Vitamin A equivalence of biofortified cassava meal with or
without oil*†
Biofortified cassava with
oil by weight
Biofortified cassava
without oil by weight
Mean SD Mean SD
4·2 3·1 4·5 3·1
* Calculated as mg of b-carotene equivalents in biofortified cassava without oil cas-
sava/mg of retinol formed.
† The present US Institute of Medicine retinol activity equivalents state that 12mg
of food-derived b-carotene equivalents form 1mg retinol(11).
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Fig. 3. b-Carotene concentration in plasma TAG-rich lipoproteins after sub-
jects ingested either 2 mg b-carotene from biofortified cassava with oil
(BFO, ) or biofortified cassava without oil (BF, ). The unfortified white
cassava, containing a negligible amount of b-carotene, was used as a control
and its concentrations at each time point were subtracted from the BFO and
BF groups. Values are means, with their standard errors represented by
vertical bars.
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The biofortified cassava used in the present study contained
b-carotene concentrations similar to those observed in other
varieties of biofortified cassava, which have concentrations
as high as 2·55 mg/100 g fresh weight(54). Therefore, the
present results may be extrapolated to other biofortified
cassava varieties. Given its substantial b-carotene concen-
trations, efficient bioconversion and the high dietary intake
of cassava in many African countries (310–820 g/d)(3), current
varieties of biofortified cassava may be suitable for food-based
interventions(54).
That being said, there remain issues with biofortified
cassava that should be addressed before it can be promoted
as a vitamin A food source and incorporated into food-
based interventions. For example, cyanide concentrations in
cassava can potentially reach toxic concentrations, typically
ranging from 10 to 500 mg cyanide equivalents/kg dry
weight(55). Nevertheless, our observation of a 50-fold variation
in cyanogenic glycoside concentration is surprising, given that
the two lots were from within the same cultivar. Variations
may be due to differences in the plants’ age and variety or
environmental factors(56). This is important information,
because biofortified cassava is likely to be grown in a variety
of conditions and climates, which might influence both
the carotenoid and cyanide concentrations of these plants.
The present results indicate that concentrations of cyanogenic
glycosides can vary significantly even in the same variety
of biofortified cassava, suggesting that great care should be
taken during its preparation.
The cassava processing method that we used to remove
cyanide was developed so that we could control the cyanide
removal process while retaining carotenoids. It is more elabo-
rate than most methods used by consumers of cassava and
requires a large amount of water. Furthermore, although the
cyanide content of the biofortified cassava from lot 2 probably
could have been removed by simple soaking, roasting or
drying, the high cyanide concentration of lot 1 would
have required more extensive processing, such as prolonged
soaking in running water or garification. Eating the cassava
from lot 2 with minimal preparation would be safe, but con-
suming the cassava from lot 1 would have been inadvisable.
Unfortunately, these procedures may negatively affect
b-carotene concentrations. Although the mild processing
techniques used in the present study resulted in a relatively
low loss of b-carotene (4 %), studies testing more common
processing procedures, such as sun-drying, boiling, frying
and gari preparation, show decreases in b-carotene concen-
tration ranging from 5·5 to 78·5 %(9,10). Therefore, when
attempting to lower cyanide content, the effects of processing
on the b-carotene content of biofortified cassava must also
be considered.
Even so, the present results are promising. These results
indicate that present cultivars of biofortified cassava may
be an effective component of food-based interventions in
vitamin A deficiency in populations who consume this food
as a staple part of their diet.
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